| Literature DB >> 25532566 |
Flore Dagorn1, Florence Buzin2, Aurélie Couzinet-Mossion3, Priscilla Decottignies4, Michèle Viau5, Vony Rabesaotra6, Gilles Barnathan7, Gaëtane Wielgosz-Collin8.
Abstract
The invasive mollusk Crepidula fornicata, occurring in large amounts in bays along the French Northeastern Atlantic coasts, may have huge environmental effects in highly productive ecosystems where shellfish are exploited. The present study aims at determining the potential economic value of this marine species in terms of exploitable substances with high added value. Lipid content and phospholipid (PL) composition of this mollusk collected on the Bourgneuf Bay were studied through four seasons. Winter specimens contained the highest lipid levels (5.3% dry weight), including 69% of PLs. Phosphatidylcholine (PC) was the major PL class all year, accounting for 63.9% to 88.9% of total PLs. Consequently, the winter specimens were then investigated for PL fatty acids (FAs), and free sterols. Dimethylacetals (DMAs) were present (10.7% of PL FA + DMA mixture) revealing the occurrence of plasmalogens. More than forty FAs were identified, including 20:5n-3 (9.4%) and 22:6n-3 (7.3%) acids. Fourteen free sterols were present, including cholesterol at 31.3% of the sterol mixture and about 40% of phytosterols. These data on lipids of C. fornicata demonstrate their positive attributes for human nutrition and health. The PL mixture, rich in PC and polyunsaturated FAs, offers an interesting alternative source of high value-added marine lecithin.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25532566 PMCID: PMC4278228 DOI: 10.3390/md12126254
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Seasonal lipid content (% dry matter) and lipid class composition (% total lipids) of the mollusk Crepidula fornicata. Values are the mean of three replicates (mean ± s.d.); s.d., standard deviation.
| Collection Season | Total Lipids | Non-Polar Lipids | Glycolipids | Phospholipids |
|---|---|---|---|---|
| Winter (January) | 5.3 ± 0.3 | 21.9 ± 0.8 | 5.5 ± 0.1 | 69 ± 1 |
| Spring (April) | 2.7 ± 0.2 | 21 ± 2 | 14.7 ± 0.2 | 62 ± 2 |
| Summer (July) | 3.3 ± 0.3 | 30 ± 1 | 13 ± 3 | 56 ± 1 |
| Autumn (November) | 3.1 ± 0.1 | 28.0 ± 0.4 | 11 ± 2 | 61 ± 1 |
Seasonal phospholipid class composition of Crepidula fornicata (% phospholipids). Values are the mean of three replicates (mean ± s.d.); s.d., standard deviation. nd, not detected.
| Phospholipid Class | Winter | Spring | Summer | Autumn |
|---|---|---|---|---|
| Cardiolipin | 6.0 ± 0.1 | 8 ± 1 | 10.1 ± 0.3 | 6.0 ± 0.6 |
| Phosphatidylethanolamine | 11.7 ± 0.3 | 2.1 ± 0.1 | 2.9 ± 0.1 | nd |
| Ceramide aminoethylphosphonate | 15.8 ± 0.2 | 11 ± 2 | 9.6 ± 0.3 | 3.7 ± 0.4 |
| Phosphatidylserine | 1.0 ± 0.1 | 1.0 ± 0.1 | nd | nd |
| Lysophosphatidylethanolamine | nd | nd | nd | 1.5 ± 0.2 |
| Phosphatidylcholine | 63.9 ± 0.3 | 76 ± 1 | 70.0 ± 0.8 | 88.9 ± 0.1 |
| Undetermined | 1.6 ± 0.1 | 2.1 ± 0.7 | 7.3 ± 0.1 | -- |
Phospholipid fatty acids of Crepidula fornicata in winter samples. a ECLs (equivalent chain lengths) were determined using column CP-Sil 5 CB. i, iso; ai, anteiso; br, branched. Values are the mean of three replicates (mean ± s.d.); s.d., standard deviation.
| Fatty Acids (Symbol) | ECL a | Abundance (wt %) |
|---|---|---|
| Saturated Fatty Acids (SFAs) | ||
| 14:0 | 14.00 | 1.13 ± 0.02 |
| 4,8,12-Me3-13:0 | 14.49 | 1.18 ± 0.03 |
| 15:0 | 15.00 | 0.62 ± 0.04 |
| 15.60 | 1.04 ± 0.03 | |
| 16:0 | 16.00 | 11.7 ± 0.6 |
| 16.64 | 2.20 ± 0.06 | |
| 16.73 | 1.36 ± 0.02 | |
| 17:0 | 17.00 | 1.49 ± 0.08 |
| 17.64 | 0.34 ± 0.01 | |
| 18:0 | 18.00 | 5.49 ± 0.09 |
| br-20:0 | 18.38 | 0.24 ± 0.01 |
| Total SFAs | -- | 27 ± 1 |
| Monounsaturated fatty acids (MUFAs) | ||
| 9-16:1 | 15.74 | 1.90 ± 0.02 |
| 7-Me-8-16:1 | 16.12 | 0.21 ± 0.01 |
| 7-Me-6( | 16.20 | 0.22 ± 0.01 |
| 7-Me-6( | 16.53 | 0.95 ± 0.05 |
| 9-18:1 | 17.72 | 4.2 ± 0.1 |
| 11-18:1 | 17.80 | 2.71 ± 0.09 |
| 11-20:1 | 19.68 | 4.85 ± 0.02 |
| 13-20:1 | 19.73 | 2.64 ± 0.05 |
| br-21:1 | 20.32 | 0.64 ± 0.01 |
| Total MUFAs | 18.3 ± 0.3 | |
| Polyunsaturated fatty acids (PUFAs) | ||
| 18:4 | 17.54 | 1.11 ± 0.04 |
| 18:2 | 17.66 | 2.11 ± 0.01 |
| 20:4 | 19.24 | 7.64 ± 0.03 |
| 20:5 | 19.34 | 9.4 ± 0.1 |
| 20:2 | 19.52 | 1.13 ± 0.04 |
| 20:2 | 19.63 | 1.52 ± 0.02 |
| 22:6 | 21.12 | 7.3 ± 0.3 |
| 22:4 | 21.19 | 1.34 ± 0.03 |
| 22:5 | 21.28 | 3.8 ± 0.1 |
| 22:3 | 21.34 | 0.36 ± 0.02 |
| 22:2 | 21.40 | 1.86 ± 0.01 |
| 22:2 | 21.46 | 6.19 ± 0.08 |
| Total PUFAs | 43.8 ± 0.8 | |
| Fatty aldehyde dimethylacetals (DMAs) | ||
| 16:0 | 16.48 | 0.63 ± 0.02 |
| br1-17:0 | 17.12 | 1.14 ± 0.02 |
| br2-17:0 | 17.22 | 1.00 ± 0.04 |
| 17:0 | 17.48 | 0.47 ± 0.06 |
| br1-18:0 | 18.10 | 0.95 ± 0.09 |
| br2-18:0 | 18.22 | 0.24 ± 0.04 |
| 18:0 | 18.48 | 3.51 ± 0.05 |
| br-19:0 | 19.22 | 0.24 ± 0.01 |
| 20:1 | 20.17 | 2.48 ± 0.03 |
| Total DMAs | 10.7 ± 0.4 | |
Minor FAs as traces (<0.2%) (ECL): i-15:0 (14.62); ai-15:0 (14.69); 22:0 (22.00); 24:0 (24.00); 4-16:1 (15.70); 11-16:1 (15.82); i-9-17:1 (16.38); 9-17:1 (16.78); 2-OH-16:0 (17.18); i-19:0 (18.61); ai-19:0 (18.72); 21:1 (20.88); 5-24:1 (23.27); 22:2n-7, 13 (19.59).
Composition of the free sterols of Crepidula fornicata in winter samples. X1, X2, X3, X4: unidentified sterols; Values are the mean of three replicates (mean ± s.d.); s.d., standard deviation.
| Systematic Names | Trivial Names | % Sterol Fraction |
|---|---|---|
| 24- | 24- | 1.24 ± 0.07 |
| 24- | 24- | 0.69 ± 0.02 |
| Cholesta-5,22 | 22 | 2.85 ± 0.04 |
| Cholesta-5,22 | 22 | 8.33 ± 0.08 |
| 5α-Cholest-22 | 22-Dehydrocholestanol | 3.13 ± 0.03 |
| 5α-Cholest-5-en-3β-ol | Cholesterol | 31.29 ± 0.04 |
| 5α-Cholestan-3β-ol | Cholestanol | 7.21 ± 0.06 |
| 24-Methylcholesta-5,22 | Brassicasterol/Crinosterol | 18.6 ± 0.1 |
| X1 (Δ° C28:0) | -- | 0.32 ± 0.01 |
| 24-Methylcholesta-5,24(28)-dien-3β-ol | 24-Methylenecholesterol | 7.32 ± .04 |
| 24-Methylcholest-5-en-3β-ol | Campesterol 22,23-Dihydrobrassicasterol | 6.72 ± 0.08 |
| X2 (Δ° C29:2) | -- | 0.54 ± 0.02 |
| 24-Ethylcholest-5,22 | Poriferasterol/Stigmasterol | 0.45 ± 0.02 |
| 24-Ethyl-5α-cholest-22 | Poriferastanol/Stigmastanol | 0.43 ± 0.01 |
| 24-Ethylcholest-5-en-3β-ol | β-Sitosterol/Clionasterol | 4.62 ± 0.07 |
| 24-Ethylcholesta-5,24(28)-dien-3β-ol | Fucosterol | 5.13 ± 0.06 |
| X3 (Δ° C30:0) | -- | 0.32 ± 0.03 |
| X4 (Δ° C30:0) | -- | 0.37 ± 0.03 |
| 22,23-Methylene-23,24-dimethylcholest-5-en-3β-ol | Gorgosterol | 0.38 ± 0.01 |
Candidates as a functional lipid from Crepidula fornicate.
| Lipids | Biological Effects | References * |
|---|---|---|
| Lecithin (polyunsaturated FAs) | Protective factor against colon cancer | [ |
| Treatment of psoriasis | [ | |
| CAEP | Implications in some hemocyte functions | [ |
| Cardiolipin | Optimization of mitochondrial respiratory performance | [ |
| Human health benefits | [ | |
| Inhibition of platelet aggregation | [ | |
| Influence to endothelial cell migration ability | [ | |
| Diunsaturated NMI FAs | Resistance to oxydative stress and microbial lipases | [ |
| Plasmalogens | Anti oxydative stress | [ |
| Phytosterols | Lowering cholesterol effects | [ |
| Action on cardiovascular disease | [ | |
| Anti-inflammatory properties | [ |
* Citation from the text. CAEP: ceramide aminoethylphosphonate; NMI: non-methylene-interrupted.